Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Biotechnology

Health Care

Biosplice Therapeutics

Cevdet Samikoglu

SAM NAMIQ

Scott Bulcao

Osman Kibar

John Hill

Jeymi Tambiah

Erich Horsley

Christopher Swearingen

The Finance and Accounting team at Biosplice Therapeutics is responsible for managing the company's financial health. This includes budgeting, financial planning, accounting, and reporting. They ensure efficient financial operations, compliance with regulations, and provide strategic financial insights to support the development of groundbreaking therapeutics in tissue-level regeneration, degenerative diseases, and oncology.

Finance and Accounting

Leadership Team

Research and Development

Clinical Operations

Finance and Accounting

About

Team members

Other teams at Biosplice Therapeutics

Leadership Team

Research and Development

Clinical Operations